Article
Controversies in clinical cancer dormancy
11 Jul 2011
Abstract excerpt
Clinical cancer dormancy is defined as an unusually long time between removal of the primary tumor and subsequent relapse in a patient who has been clinically disease-free. The condition is frequently observed in certain carcinomas (e.g., breast cancer), B-cell lymphoma, and melanoma, with relapse occurring 5-25 y later. Clinical data suggest that a majority of breast cancer survivors have cancer cells for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
